In summary, our study validated the methods for developing human brain organoids from iPSCs derived from GLUT1-DS patients and demonstrated that these organoids exhibit epileptiform features when compared to those developed from healthy iPSCs. Here, SLC2A1 is linked to Dravet syndrome.